Status:
RECRUITING
Local Tranexamic Acid During Vaginal Hysteractomy to Reduce Blood Loss
Lead Sponsor:
Meir Medical Center
Conditions:
Blood Loss
Eligibility:
FEMALE
20-90 years
Phase:
NA
Brief Summary
Assessing the efficiency of Prophylactic use of local tranexamic acid during vaginal hysterectomy to reduce blood loss during operation
Detailed Description
This randomized control trial will investigate whether local tranexamic acid is efficient for decreasing bleeding during vaginal hysterectomy. The investigators will randomize local placebo (saline) ...
Eligibility Criteria
Inclusion
- 20-90 years old female patients going through vaginal hysterctomy
Exclusion
- massive bleeding during operation due to major vessles injury
- known coagulopathies
- sensitivity to tranexamic acid
- medical need in tranexamic acid administration during operation due to bleeding
Key Trial Info
Start Date :
February 16 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04760301
Start Date
February 16 2021
End Date
June 1 2026
Last Update
May 6 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Meir Medical Center
Kfar Saba, Israel, Israel, 11125
2
Meir medical center
Kfar Saba, Israel